Few topics in recovery carry more stale stigma than medication. So let's say the current mainstream position plainly: for opioid use disorder in particular, medication is a first-line, evidence-supported treatment — endorsed by SAMHSA, NIDA, and essentially every major medical body. People on stable MAT are not "still using." They are in recovery, by the definition that matters: getting their lives back.
The three main medications
Buprenorphine (often known by the brand Suboxone) partially activates opioid receptors — enough to stop withdrawal and craving, with a ceiling that makes misuse and overdose far less likely. Prescribed in regular medical offices and by telehealth, which has made it dramatically more accessible.
Methadone fully activates the receptors under tightly controlled dosing through certified opioid treatment programs. Decades of evidence; especially relevant for people with long, heavy opioid histories or for whom buprenorphine hasn't held.
Naltrexone (including the monthly Vivitrol injection) is the opposite mechanism: a blocker with no opioid effect at all. It requires full detox first. It's also one of the medications used for alcohol use disorder, where it reduces craving and heavy-drinking days — a fact many families never hear.
What the evidence says
Across studies, staying on buprenorphine or methadone is associated with large reductions in overdose death, illicit use, infectious disease, and dropout from treatment compared with non-medication approaches for opioid use disorder. That mortality point deserves repeating in the fentanyl era: the most dangerous stretches are the gaps — after a detox, after leaving a program, after "just stopping the meds." Medication narrows those gaps.
Not medical advice — a conversation starter. Which medication, at what dose, for how long, is a decision between a patient and a prescriber who knows the full picture. This guide's job is only to make sure nobody rules out the standard of care because of stigma.
"But isn't it trading one drug for another?"
The dinner-table question. The distinction that answers it: addiction is compulsive use despite worsening consequences. Stable, prescribed medication produces the reverse — steady dosing, no intoxication at treatment doses, and a life that expands instead of shrinking. Nobody asks a person with diabetes when they'll be "really healthy" and stop insulin. Some people taper off MAT eventually; others stay on it for years. Both are recovery when the life is working.
How long?
The honest answer: as long as it's helping, decided with a prescriber, unhurried. Research generally cautions against short, arbitrary timelines — relapse and overdose risk spike after early discontinuation. A useful family agreement: judge the life (work, relationships, stability), not the calendar.
Practical notes
- Cost: Medicaid and most insurance cover MAT; parity rules apply. Generic buprenorphine is inexpensive compared with almost any alternative outcome.
- Finding it: filter our directory for MAT, or ask any center directly: "Do you support medication, or discourage it?" A program that discourages it for opioid recovery is out of step with the evidence — treat that as a red flag.
- Naloxone (Narcan) is separate and for everyone: it reverses overdoses and is now available over the counter. Any household touched by opioids should have it, the way kitchens have fire extinguishers.